Cyclo Therapeutics Inc (CYTH) Inventory Turnover Ratio, from third quarter 2024 to third quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Cyclo Therapeutics Inc   (NASDAQ: CYTH)
 

Cyclo Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cyclo Therapeutics Inc inventory turnover ratio, the Cyclo Therapeutics Inc 's ability to sell and replace its inventory in the third quarter 2024, sequentially increased to 0.52 in the third quarter 2024, a new company high. Average inventory processing period, for the Cyclo Therapeutics Inc in Sep 30 2024 quarter, has decreased to 702 days, compare to 793 days, in the Jun 30 2024 quarter.

Within Healthcare sector 395 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1478 in the second quarter 2024, to 1511.

CYTH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cyclo Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYTH Inventory Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Inventory Growth 12.56 % 1.85 % -0.8 % -0.05 % -22.64 %
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.52 0.46 0.41 0.36 -
CYTH's Total Ranking # 1511 # 1478 # 1358 # 0 # 0
Average inventory processing period 703 789 895 1022 -
Seq. Inventory Growth -2.04 % -0.62 % -4.65 % 21.26 % -11.36 %
Seq. Cost of Sales Growth 25.54 % 13.18 % -85.99 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 396
Overall Market # 1511

Inventory Turnover Ratio Statistics
High Average Low
0.52 0.34 0.18
(Sep 30 2024)   (Sep 30 2020)



CYTH Company Profile >> Back to CYTH Efficiency Comparisons >> Compare CYTH Inventory Turnover Ratio to its Competitors

Financial Statements
Cyclo Therapeutics Inc 's Inventories $ 0 Millions Visit CYTH's Balance sheet
Cyclo Therapeutics Inc 's Cost of Revenues TTM $ 0 Millions Visit CYTH's Income Statement
What are CYTH's Sales? Visit CYTH's Sales by Segment

Other Inventory Turnover Ratios
Cyclo Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CYTH's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CYTH's Competitors
Inventory Turnover Ratio for CYTH's Suppliers
Inventory Turnover Ratio for CYTH's Customers

You may also want to know
CYTH's Sales Growth Rates CYTH's Pe Price to earnings ratio CYTH's Receivables Turnover Ratio CYTH's Stock Quote
CYTH's Net Income Growth Rates CYTH's Ps Price to Sales ratio CYTH's Sales per Employee CYTH's Asset Turnover Ratio
CYTH's Net Margin CYTH's Pb Price to Book ratio CYTH's Financial Strength Ratios CYTH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2024 Inventories at quarter ending Sep 30 2024
Lakeland Industries Inc   1.46 $ 90.638  Millions$ 62  Millions
Zai Lab Limited  1.45 $ 59.289  Millions$ 41  Millions
Insulet Corporation  1.42 $ 607.900  Millions$ 427  Millions
Cv Sciences Inc   1.41 $ 7.634  Millions$ 5  Millions
Kyntra Bio Inc   1.41 $ 41.632  Millions$ 30  Millions
Zomedica Corp   1.39 $ 7.353  Millions$ 5  Millions
Cumberland Pharmaceuticals Inc   1.38 $ 6.139  Millions$ 4  Millions
Orchestra Biomed Holdings Inc   1.37 $ 0.193  Millions$ 0  Millions
Avita Medical Inc   1.35 $ 8.690  Millions$ 6  Millions
Outset Medical Inc   1.35 $ 76.960  Millions$ 57  Millions
Iradimed Corporation  1.34 $ 16.303  Millions$ 12  Millions
Keenova Therapeutics Plc  1.33 $ 1,133.000  Millions$ 850  Millions
Biolife Solutions Inc   1.33 $ 50.491  Millions$ 38  Millions
Trisalus Life Sciences Inc   1.33 $ 4.294  Millions$ 3  Millions
Globus Medical Inc   1.32 $ 1,037.528  Millions$ 788  Millions
Alkermes Plc   1.31 $ 253.308  Millions$ 193  Millions
Electrocore Inc   1.31 $ 3.022  Millions$ 2  Millions
Nuo Therapeutics Inc   1.28 $ 0.258  Millions$ 0  Millions
Sensus Healthcare Inc   1.26 $ 16.152  Millions$ 13  Millions
Travere Therapeutics Inc   1.25 $ 8.237  Millions$ 7  Millions
Corcept Therapeutics Inc  1.25 $ 9.802  Millions$ 8  Millions
Beone Medicines Ltd   1.24 $ 536.912  Millions$ 435  Millions
Tenet Healthcare Corp  1.23 $ 474.000  Millions$ 386  Millions
Elanco Animal Health Incorporated  1.22 $ 2,018.000  Millions$ 1,654  Millions
Nuwellis Inc   1.21 $ 2.410  Millions$ 2  Millions
Eli Lilly And Company  1.21 $ 7,802.500  Millions$ 6,454  Millions
Rhythm Pharmaceuticals Inc   1.19 $ 12.815  Millions$ 11  Millions
Y mabs Therapeutics inc   1.19 $ 9.398  Millions$ 8  Millions
Ss Innovations International Inc  1.18 $ 8.412  Millions$ 7  Millions
Halozyme Therapeutics Inc   1.16 $ 169.660  Millions$ 147  Millions

Date modified: 2026-06-22T14:32:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.